2 Reasons Barclays Expects Record Highs for Nvidia Stock

CTMX is soaring out of the gate thanks to the company's deal with Amgen

Oct 4, 2017 at 10:20 AM
facebook X logo linkedin

Analysts are weighing in on video game maker Electronic Arts Inc. (NASDAQ:EA), semiconductor stock NVIDIA Corporation (NASADQ:NVDA), and biotech CytomX Therapeutics Inc (NASDAQ:CTMX). Here's a quick roundup of today's bullish brokerage notes on shares of EA, NVDA, and CTMX.

Electronic Arts Stock Dips Despite Bullish Analyst Note

Electronic Arts stock is down 1.2% to trade at $116.55, despite bullish attention from Barclays. The brokerage firm started coverage on the video game stock with an "overweight" rating and a price target of $129 -- in uncharted territory. Analysts there expect the company to benefit from the gaming community's shift to digital products. 

EA shares have been climbing the charts this year, adding roughly 50% in value in 2017. Recently pulling back from an Aug. 31 record high of $122.79, the security bounced off its 100-day moving average. Meanwhile, all but three of the 17 analysts following the stock rate it a "buy" or better, with not a single "sell" in sight.

Analyst Predicts Record Highs for NVIDIA Stock

Another security on Barclays' radar today is NVIDIA stock, last seen trading 0.5% lower at $178.55. The brokerage firm raised its price target to $200 from $140 -- record-high territory -- citing optimism for the company's position in the cryptocurrency market and the launch of its Volta-based graphic processing units (GPU). This is much of the same for the semiconductor stock, which has added 162% in value over the past year and hit a record high of $191.20 on Sept. 18. Not all analysts are convinced, however, as half of the 24 brokerage firms following the equity rate it a "hold" or worse. What's more, NVDA's average 12-month target price sits at $164.23 -- equating to an 8% drop from current levels. 

Amgen Deal Sends CytomX Stock to Fresh Highs

CytomX Therapeutics stock ranks among the top percentage gainers on the Nasdaq today, after the biotech announced its strategic collaboration with Amgen to co-develop new cancer treatments. As part of the deal, Amgen will pay CytomX $40 million and buy $20 million worth of its stock. In response, Wedbush and Nomura raised their price targets on CTMX stock to $37 and to $44, respectively.

After hitting an annual high of $24.67 earlier, the shares are trading at $23.42, up 23.3% on the day. The biotech stock has now more than doubled on a year-to-date basis, and short sellers are jumping ship. Short interest on CTMX decreased 4.7% during the last reporting period to just 1.22 million shares. It would still take more than three sessions to cover these shorted shares, however, at the equity's average daily trading volume.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI